In collaboration with an Indian partner, ICPE is conducting a comprehensive market study to assist Jafral, a company specializing in bacteriophage technology, in expanding into the Indian market. The study includes a thorough examination of market potential, alongside bacteriological testing to ensure the effectiveness of Jafral’s solutions against local bacterial strains. This initiative reflects ICPE’s dedication to fostering cross-border innovation and supporting member states in adopting cutting-edge health technologies that can address region-specific challenges.